All News

New York's cannabis industry has grown to over $2 billion. The OCM's update shows market rebound and new support for equity applicants.

The FY26 CJS Appropriations Act includes Section 607, barring cannabis rescheduling. Advocates warn the Act threatens medical cannabis protections.

The OCM is taking action against Lexachrom Laboratory for regulatory failures and significant violations, jeopardizing consumer safety and market integrity.

The Texas Cannabis Policy Center and Texas Hemp Business Council both support Governor Abbott’s executive order on hemp regulations.

Our top five cannabis and hemp news this week: Nebraska’s medical cannabis battle, rescheduling debate, Thailand policy shifts, new medical cannabis research, and pricing trends.

This month’s Healer webinar, led by Dustin Sulak, DO, explores new medical cannabis research including potential benefits for cancer, wound healing, ALS, Alzheimer’s, and terpenes like alpha-pinene.

Texas Governor Greg Abbott issues an executive order to regulate product sales, requiring ID checks and testing.

New York's legal cannabis sales top $2 billion, with 46 new licenses approved. The state is prioritizing social equity and new education panels.

In this interview, Steve Allin, director of the International Hemp Building Association shares insights on the versatility and benefits of hemp as a crop and as a material used in construction.

An examination of survey data finds state cannabis laws strongly shape delta-8-THC use, with highest rates in prohibition states.

What's driving the cannabis pricing crisis? Test your knowledge regarding the market forces and trends that are reshaping the industry for 2025.

Citing risks to children, health, and public safety, nine Congress members sent a letter to Attorney General Pam Bondi and President Donald Trump, opposing the rescheduling of cannabis.

The Maryland Comptroller reports nearly $18.4 million in Q2 cannabis tax revenue. The Central region, including Baltimore, generated the most income.

Nebraska’s cannabis commission approves restrictive rules, limiting patient access and business licenses.

Here, we bring you our top five recent articles covering federal hemp ban, an interview with Reginald Gaudino, PhD, the reintroduced MORE Act, Delaware cannabis sales and rezoning, and restricting intoxicating hemp-derived cannabinoids.

Recent research highlights the potential of cannabinoids as alternative treatments for atopic dermatitis, showcasing their anti-inflammatory and antibacterial properties.

Delaware's first month of recreational marijuana sales was a success at over $7 million, but the veto of SB 75 shows an ongoing zoning debate.

The organization voiced its support of Texas and other states restricting synthetic hemp cannabinoids, urging science-based regulation to protect consumers, businesses, and public safety.

THC drinks are shaping a new drinking culture. A recent report dives into market growth, state regulations, and the challenges facing the industry.

The MORE Act, a federal cannabis reform bill, has recently been reintroduced to US Congress, with plans to deschedule cannabis and expunge convictions.

As more studies are being conducted on multiple parts of the cannabis plant, this study tested the root samples against four cancer cell lines, finding evidence of antiproliferation effects.

Hemp has the potential to be a sustainable resource for textiles and building materials, but it still has to overcome the stigma and regulatory hurdles that challenge its widespread adoption.

This article explores the dual challenge of cannabis decontamination and preservation, highlighting technology and best practices that protect consumers, maintain product integrity, and build trust.

In this interview clip from our Higher Education: Research Initiatives That Deepen Our Understanding of Cannabis supplement, Reginald Gaudino, PhD explains The Cannabis Research Institute and its studies on cannabis and hemp's societal impacts, informing policy and promoting equity and research in Illinois.

Here, we bring you our top five recent articles covering a $3.6 million grant for Minnesota’s cannabis industry, kidney disease and cannabis use, banking reform, flavoalkaloids in leaves, and CBD and liver enzyme levels.

Traditional cannabis preservation methods like glass jars or plastic bags fail to address the complex biochemical processes that lead to degradation. New packaging solutions create a controlled microclimate to maintain an ideal relative humidity between 58% and 62% and manage gas exchange to prevent degradation. This technology benefits cultivators with greater product stability, processors with higher-quality starting material, and consumers who receive a consistent product.

Two organizations with opposing views recently prepared letters to the Trump Administration on the anticipated action regarding cannabis reclassification.

In this interview clip from our July/August issue, Carly Bader explains how preventing cannabis contamination requires a system-based approach, including routine monitoring of the entire cultivation environment.